In a study directly comparing the murine and human versions of an anti-GPC-1 CAR T cell, the murine version only demonstrated in vitro tumor cell lysis at 80:1 in contrast to 5:1 for the human construct. This evidence concerns the gene GPC1 and neoplasm.